Shire Prices $12.1B Bond To Help Pay For Baxalta Deal
Irish biopharmaceutical giant Shire said Monday it priced $12.1 billion in bonds to help fund its $32 billion acquisition of Baxalta, marking the latest corporation to tap historically cheap debt capital...To view the full article, register now.
Already a subscriber? Click here to view full article